Resource

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.

Ogawa, Hisao; Nakayama, Masafumi; Morimoto, Takeshi; Uemura, Shiro; Kanauchi, Masao; Doi, Naofumi; Jinnouchi, Hideaki; Sugiyama, Seigo; Saito, Yoshihiko
JAMA : the journal of the American Medical Association; 2008 Nov 12;300(18):2134-41. PMID: 18997198
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto City, 860-8556, Japan. ogawah@kumamoto-u.ac.jp
Category: 
Interventions
Links: 
PubMed Article
Journal Article

Abstract

Previous trials have investigated the effects of low-dose aspirin on primary prevention of cardiovascular events, but not in patients with type 2 diabetes.